Unjha Formulations Limited (UNJHAFOR.BO)
BSE
Healthcare
Drug Manufacturers - Specialty & Generic
$27.55
▲ +2.04%
Market Cap
$123.4M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.24
52-Wk Range
17.52-29.5
CEO
Krutiben Mayankkumar Patel
Country
IN
Currency
INR
Unjha Formulations Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Sidhpur, GU, IN. The stock last traded at $27.55, up 2.04% on the session, giving a market capitalisation of $123.4M. Its beta of -0.24 implies it has historically moved less than the broad market.
Company profile
Exchange
Bombay Stock Exchange
Employees
17
IPO date
2002-01-03
Headquarters
Sidhpur, GU, IN
About Unjha Formulations Limited
Unjha Formulations Ltd. primarily manufactures and exports traditional Ayurvedic goods. Their offerings encompass products such as Anchor Sat-Isabgol, Fibron, and Fibron SF. The enterprise commenced operations on September 2, 1994, and its main administrative hub is situated in Sidhpur, India.
Comparable companies
Unjha Formulations Limited is most often compared with the following Healthcare names:
More research on UNJHAFOR.BO
Open full interactive analysis & DCF →